Chugai Commits $220M Into Singapore Drug Lab Post author:Sam Post published:December 28, 2017 Post category:BioPharma The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace You Might Also Like Novartis AG Pushes A NASH Combo Into Late-Stage Development With A Little Help From Its Friend Allergan April 17, 2017 Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ May 7, 2017 Hebron Technology Co. Signs Framework Agreement To Form JV With Ukrainian Company June 25, 2017
Novartis AG Pushes A NASH Combo Into Late-Stage Development With A Little Help From Its Friend Allergan April 17, 2017
